连花清瘟胶囊治疗肺部感染30例疗效观察

目的：观察连花清瘟胶囊治疗肺部感染的疗效。方法：将临床确诊为肺部感染的60例患者随机分为2组。对照组30例采用头孢曲松钠或乳酸左氧氟沙星治疗,治疗组在对照组的基础上加用连花清瘟胶囊口服,疗程7d。疗程结束后观察2组细菌学疗效、临床症状及体征的变化和总有效率,并观察药物不良反应。结果：治疗后细菌清除率治疗组为80.0%,而对照组为50.0%;临床总有效率治疗组为96.7%,而对照组为83.3%,2组比较差异具有统计学意义（P〈0.05）;不良反应发生率治疗组为33.3%,对照组为26.7%,2组比较差异无统计学意义（P〉0.05）。结论：连花清瘟胶囊治疗肺部感染疗效显著,药物安全性好。

Observation of Efficacy of Lianhua Qingwen Capsule on Lung Infection

Objective： To observe the efficacy of Lianhua Qingwen Capsule on lung infection. Methods ： Sixty patients with lung infection were randomly grouped to control group receiving ceftriaxone sodium or Lavofloxacin Lactate, and treatmerlt group receiving Lianhua Qingwen Capsule in additional to controlled medication for 7 days. To observe bacteria clearance rate, clinical manifestation, physical signs, total effective rate, and untoward actions respectively. Results ： The bacteria clearance rate of the treatment group was 80.0% compared to 50.0% of the control group, the total effective rate of the treatment group was 96.7% compared to 83.3% of the control group （ P 〈 0.05 ）. Untoward action incidence rate of the treatment group was 33.3 % compared to 26.7% of the control group （ P 〉 O. 05 ）. Conclusion：Lianhua Qingwen Capsule is safe and has significant efficacy for lung infection.